Introduction
The fi lamentous fungus Aspergillus fumigatus is an important invasive pathogen of immunocompromised humans and a producer of many allergen proteins. While the incidence of invasive aspergillosis (IA) cases is not high ( ∼ 5 cases per year in a group of surveyed hospitals [1] ; IA in ∼ 2% of haematopoetic stem cell transplants [2] ), crude mortality rates of ∼ 50 -80% have been reported for patients with aspergillosis [2] . As a consequence, considerable effort is being expended in the improvement of our understanding of A. fumigatus biology, as well as in the identifi cation of anti-fungal drugs. Much has been achieved at the genome level, with the completion of the A. fumigatus Af293 genome sequence [3] , the publication of comparative genome analyses [4, 5] and the provision of the publicly available genomics resources CADRE [6], 
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Automatic identifi cation and assignment of enzymes using the PathoLogic tool resulted in 244 pathways. A pathway hole report was then generated, identifying 276 ' holes ' , i.e., reactions to which no enzyme had been assigned. These holes were manually inspected to identify and assign a gene where possible. In many cases the following strategies were used: (i) searches of Gen-Bank using enzyme names or EC numbers; (ii) Blast searches of A. fumigatus sequences with annotated sequences from other organisms; (iii) Pubmed searches using enzyme names; (iv) Comparison with Saccharomyces cerevisiae pathways (http://pathway.yeastgenome. org/); (v) Comparison with the pathways available on MetaCyc (http://metacyc.org/; [12] ). In some cases this optimization process led to the deletion of reactions or pathways if it seemed highly probable that these were absent from A. fumigatus . A number of pathways were examined in detail and all their component reactions checked.
Results

Automated analysis of the annotated A. fumigatus
Af293 genome by Pathway Tools, followed by manual inspection of holes and certain key pathways resulted in a pathway database of 242 pathways and 1576 reactions (Table 1) . Nine pathways were annotated in detail (annotation level 1 in Table 1 ), including examination of literature where appropriate, with attention being paid to ergosterol biosynthesis, 4-hydroxymandelate degradation, fatty acid β -oxidation, fatty acid ω -oxidation, the glyoxylate cycle, palmitate biosynthesis, pyridoxal 5′-phosphate salvage, sphingolipid metabolism, ubiquinone biosynthesis and very long chain fatty acid biosynthesis. The ergosterol biosynthesis pathway, ' alternative ergosterol biosynthesis pathway ( A. fumigatus ) ' , was of particular interest as it is the site of action of the antifungal azoles, which inhibit lanosterol demethylase (cyp51/ ERG11), and also of the allylamines (such as terbinafi ne) which inhibit a preceding enzyme, squalene epoxidase (ERG7).
The pathway database can be accessed via the Scientifi c Information;Genomes section of the Aspergillus website (www.aspergillus.org.uk); pathways may be viewed and downloaded with different levels of detail and it is possible to examine annotations and the level of supporting evidence. PDF views of a number of key pathways will be made available at the Aspergillus website and it is anticipated that the ' knowledgebase ' fi les will be made available for download so that local copies can be established by any laboratory running the Pathway Tools software. Mycology, 49(Suppl. 1) , S114-S119 Metabolic pathways of A. fumigatus Af293 S117
Discussion
The mapping of metabolic and biosynthetic pathways of A. fumigatus Af293 represents the next step after genomic analysis in the understanding of the biology of this organism, and access to 242 pathways and 1576 reactions is now available. The level of annotation for a given pathway is chiefl y dependent on the extent to which it has received attention; thus within this database, as with others, there are some pathways that are well attested, some for which there is less evidence, and others where their existence in A. fumigatus has yet to be demonstrated. For the clinician with an interest in Aspergillosis, but without the expertise in genomics or fungal pathways, this resource provides a starting point for entry into Aspergillus biology, providing an answer to the question " How does Aspergillus fumigatus do that? " For researchers with more in-depth knowledge, the pathway resource will help advance Aspergillus biology: For instance, in mode-ofaction screens for drug mechanisms, the pathways and component genes that are implicated can be easily accessed from the outset, without having to mine the literature. Similarly, this resource will make it simpler to identify the fungal equivalents of human pathway components for comparisons which can be of value for better understanding of their function [28, 29] . There are also features available in PathwayTools for comparison of the complete A. fumigatus pathway repertoire with that of other annotated genomes, enabling appreciation of similarities and differences compared to other fungi and humans.
In conclusion, the establishment of a curatable public facility for A. fumigatus Af293 pathways acts as the starting point for building a comprehensive resource and provides a tool comparable to that currently available for Saccharomyces cerevisiae (http://pathway.yeastgenome.org/) and Candida albicans (http://pathway.candidagenome.org/).
